急性心肌梗死与缺血性卒中再灌注治疗的异同
本综述对比急性ST段抬高型心肌梗死(STEMI)与急性缺血性卒中(AIS)在再灌注治疗上的异同。两者均强调快速治疗,纤溶治疗均先于血管内技术应用;但AIS仅少数患者最终符合再灌注条件,脑成像先于脑血管造影和取栓,而STEMI不常规先行无创心脏成像。STEMI指南仍推荐症状发作后12小时内统一再灌注时间窗,AIS以桥接纤溶后血管内治疗为主,STEMI首选直接经皮冠状动脉介入治疗。
要点
- STEMI与AIS均需快速再灌注,但病理生理差异要求疾病定制化策略。
- AIS仅少数患者最终符合再灌注治疗条件,脑成像先于脑血管造影和取栓。
- STEMI指南仍推荐症状发作后12小时内统一再灌注时间窗,AIS以桥接纤溶后血管内治疗为主。
核心结论
- STEMI与AIS再灌注策略存在重要差异,需疾病定制化方法。
- 缩短缺血时间、优化桥接纤溶和减轻缺血再灌注损伤是进一步研究方向。
研究设计与样本
- 综述,比较STEMI与AIS再灌注治疗的病理生理与策略异同。
主要发现
- 两者均强调快速治疗,纤溶治疗均先于血管内技术应用。
- AIS仅少数患者最终符合再灌注治疗条件。
- AIS脑成像先于脑血管造影和取栓,STEMI不常规先行无创心脏成像。
- STEMI指南仍推荐症状发作后12小时内统一再灌注时间窗。
- AIS以桥接纤溶后血管内治疗为主,STEMI首选直接经皮冠状动脉介入治疗。
关键数值与推荐
- STEMI指南推荐症状发作后12小时内再灌注时间窗。
- AIS中桥接纤溶后血管内治疗仍是再灌注治疗的主要方式。
临床怎么用
- STEMI应遵循12小时内再灌注时间窗并首选直接PCI。
- AIS应先行脑成像评估再灌注资格,桥接纤溶后行血管内治疗。
- 优化急救网络协作以缩短缺血时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute ST-elevation myocardial infarction (STEMI) and acute ischaemic stroke (AIS) share a number of similarities. However, important differences in pathophysiology demand a disease-tailored approach. In both conditions, fast treatment plays a crucial role as ischaemia and eventually infarction develop rapidly. Furthermore, in both fields, the introduction of fibrinolytic treatments historically preceded the implementation of endovascular techniques. However, in contrast to STEMI, only a minority of AIS patients will eventually be considered eligible for reperfusion treatment. Non-invasive cerebral imaging always precedes cerebral angiography and thrombectomy, whereas coronary angiography is not routinely preceded by non-invasive cardiac imaging in patients with STEMI. In the late or unknown time window, the presence of specific patterns on brain imaging may help identify AIS patients who benefit most from reperfusion treatment. For STEMI, a uniform time window for reperfusion up to 12 h after symptom onset, based on old placebo-controlled trials, is still recommended in guidelines and generally applied. Bridging fibrinolysis preceding endovascular treatment still remains the mainstay of reperfusion treatment in AIS, while primary percutaneous coronary intervention is the strategy of choice in STEMI. Shortening ischaemic times by fine-tuning collaboration networks between ambulances, community hospitals, and tertiary care hospitals, optimizing bridging fibrinolysis, and reducing ischaemia-reperfusion injury are important topics for further research. The aim of this review is to provide insights into the common as well as diverging pathophysiology behind current reperfusion strategies and to explore new ways to enhance their clinical benefit.
引用
- Scheldeman, Sinnaeve, Albers, et al. Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review. Eur Heart J. 2024. PMID: 38941344. doi:10.1093/eurheartj/ehae371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。